MX2016013947A - USE OF THE OXYMATE OF THE ACETATE OF THE 23 (S) -ACETILDIOSGENINE AS ANTICHANCERIGEN IN CANCER CERVICOUTERINO. - Google Patents
USE OF THE OXYMATE OF THE ACETATE OF THE 23 (S) -ACETILDIOSGENINE AS ANTICHANCERIGEN IN CANCER CERVICOUTERINO.Info
- Publication number
- MX2016013947A MX2016013947A MX2016013947A MX2016013947A MX2016013947A MX 2016013947 A MX2016013947 A MX 2016013947A MX 2016013947 A MX2016013947 A MX 2016013947A MX 2016013947 A MX2016013947 A MX 2016013947A MX 2016013947 A MX2016013947 A MX 2016013947A
- Authority
- MX
- Mexico
- Prior art keywords
- acetate
- cancer
- cervicouterino
- antichancerigen
- acetildiosgenine
- Prior art date
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 102000003952 Caspase 3 Human genes 0.000 abstract 1
- 108090000397 Caspase 3 Proteins 0.000 abstract 1
- 206010008342 Cervix carcinoma Diseases 0.000 abstract 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 201000010881 cervical cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- -1 oxime compound Chemical class 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
La presente invención describe al compuesto oxima de acetato de la 23(S)-acetildiosgenina, así como su uso farmacéutico para el tratamiento de cáncer cervicouterino. Dicho compuesto demostró su actividad anti-noeplásica a través la inducción de la apoptosis dependiente de caspasa-3 en células tumorales.The present invention describes the oxime compound of 23 (S) -acetyldiosgenin acetate, as well as its pharmaceutical use for the treatment of cervical cancer. Said compound demonstrated its anti-noeplastic activity through the induction of caspase-3-dependent apoptosis in tumor cells.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2016013947A MX384601B (en) | 2016-10-24 | 2016-10-24 | USE OF 23(S)-ACETYLDIOSGENIN ACETATE OXIME AS AN ANTICANCER AGENT IN CERVICAL CANCER. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2016013947A MX384601B (en) | 2016-10-24 | 2016-10-24 | USE OF 23(S)-ACETYLDIOSGENIN ACETATE OXIME AS AN ANTICANCER AGENT IN CERVICAL CANCER. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016013947A true MX2016013947A (en) | 2018-04-23 |
| MX384601B MX384601B (en) | 2025-03-14 |
Family
ID=62778555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016013947A MX384601B (en) | 2016-10-24 | 2016-10-24 | USE OF 23(S)-ACETYLDIOSGENIN ACETATE OXIME AS AN ANTICANCER AGENT IN CERVICAL CANCER. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX384601B (en) |
-
2016
- 2016-10-24 MX MX2016013947A patent/MX384601B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX384601B (en) | 2025-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP19020740A (en) | ANTI-CD27 ANTIBODIES | |
| JOP20200192A1 (en) | TIGIT . antibodies | |
| MX2017006283A (en) | USEFUL MACROCICLIC PEPTIDES AS IMMUNOMODULATORS. | |
| EP4552697A3 (en) | Protein kinase c inhibitors and methods of their use | |
| CO2017005566A2 (en) | Cyclic peptides derived from cd44v6 for the treatment of diseases related to cancers and angiogenesis | |
| NZ734750A (en) | Cancer therapy with a parvovirus combined with bevacizumab | |
| MX375318B (en) | DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLORINE KYNURENINE. | |
| BR112017016333A2 (en) | anticancer compounds | |
| CO2020004984A2 (en) | Process to prepare benzothiophen-2-yl boronate | |
| MX2016013947A (en) | USE OF THE OXYMATE OF THE ACETATE OF THE 23 (S) -ACETILDIOSGENINE AS ANTICHANCERIGEN IN CANCER CERVICOUTERINO. | |
| AR120118A2 (en) | ANTI-TIGIT ANTIBODIES | |
| MX2016013945A (en) | USE OF THE DIOXYM OF THE (25R) -ESPIROST-4-EN-3,6-DIONA AS ANTI-BANERIGENE IN CANCER CERVICOUTERINO. |